Toward a Pragmatic Policy on Authorship

Alemayehu Demissie and Levenstein Marcia
Additional contact information
Alemayehu Demissie: Pfizer Inc.
Levenstein Marcia: Pfizer Inc.

Statistics, Politics and Policy, 2011, vol. 2, issue 1, 12

Abstract: There has been growing concern about ghostwriting practices in peer-reviewed biomedical journals. As a result, various proposals have been put forth to abolish or prevent the practice of ghostwriting. In this article, we review the issues underlying ghostwriting in medical research; highlight the shared responsibilities of the pharmaceutical industry and other trial sponsors, medical centers and journal editors; and propose a roadmap for an effective policy on the ethical, transparent and reliable communication of results of clinical research.

Keywords: ghostwriting; transparency; medical writing; conflict of interest; publication; disclosure (search for similar items in EconPapers)
Date: 2011
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://doi.org/10.2202/2151-7509.1034 (text/html)
For access to full text, subscription to the journal or payment for the individual article is required.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bpj:statpp:v:2:y:2011:i:1:p:12:n:2

Ordering information: This journal article can be ordered from
https://www.degruyter.com/journal/key/spp/html

DOI: 10.2202/2151-7509.1034

Access Statistics for this article

Statistics, Politics and Policy is currently edited by Joel A. Middleton

More articles in Statistics, Politics and Policy from De Gruyter
Bibliographic data for series maintained by Peter Golla ().